Clinical Trial Update: Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial evaluating vatalanib for patients with primary or secondary myelodysplastic syndromes, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Drugs mentioned

• Vatalanib (vatalanib)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2014-06-24